Adaptimmune Therapeutics
ADAP
#8447
Rank
NZ$0.27 B
Marketcap
$1.07
Share price
0.82%
Change (1 day)
34.70%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: NZ$0.27 Billion

As of December 2024 Adaptimmune Therapeutics has a market cap of NZ$0.27 Billion. This makes Adaptimmune Therapeutics the world's 8447th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.27 B-3.87%
2023NZ$0.28 B-24.4%
2022NZ$0.37 B-56.07%
2021NZ$0.85 B-25.84%
2020NZ$1.15 B517.08%
2019NZ$0.18 B-79.1%
2018NZ$0.89 B1.73%
2017NZ$0.88 B112.92%
2016NZ$0.41 B-66.82%
2015NZ$1.24 B

End of Day market cap according to different sources

On Dec 22nd, 2024 the market cap of Adaptimmune Therapeutics was reported to be:

NZ$0.27 Billion
by Nasdaq info icon info icon
NZ$0.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$2.46 B 800.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$70.47 M-74.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.46 B 434.72%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$16.81 B 6,042.07%๐Ÿ‡บ๐Ÿ‡ธ USA